The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Precision Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Precision Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1755037

No of Pages : 101

Ask Your Query

Synopsis
The global Precision Oncology market size was valued at USD 98260 million in 2022 and is forecast to a readjusted size of USD 184270 million by 2029 with a CAGR of 9.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.

Precision oncology is a field of medicine that uses genetic information to adapt cancer treatment to an individual’s specific tumor and biology. It is also known as personalized medicine or precision medicine. Precision oncology identifies the unique genetic mutations and other molecular characteristics of a patient’s tumor, and then uses that information to choose the most effective treatment. This approach takes into account the genetic differences between tumors and the genetic variations among individuals and allows for targeted and effective treatment options. Precision oncology techniques include genomic profiling, which analyzes the genetic makeup of a tumor, and liquid biopsies, which detect tumor DNA in the bloodstream. This information can be used to match patients with targeted therapies that are designed to specifically target the molecular abnormalities in their tumor.

This report is a detailed and comprehensive analysis for global Precision Oncology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Precision Oncology market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Precision Oncology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Precision Oncology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Precision Oncology market shares of main players, in revenue ($ Million), 2018-2023.

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Precision Oncology
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace.

This report profiles key players in the global Precision Oncology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acrivon Therapeutics, Bio-Serv, Exact Sciences Corporation, Illumina, Inc. and Invitae Corporation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Precision Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Diagnostics
  • Therapeutics

Market segment by Application

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Healthcare Data Companies

Market segment by players, this report covers

  • Acrivon Therapeutics
  • Bio-Serv
  • Exact Sciences Corporation
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America
  • QIAGEN
  • Rain Oncology
  • Relay Therapeutics
  • Strata Oncology, Inc.
  • Thermo Fisher Scientific Inc.
  • Variantyx, Inc.

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Precision Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Precision Oncology, with revenue, gross margin and global market share of Precision Oncology from 2018 to 2023.
Chapter 3, the Precision Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Precision Oncology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Oncology.
Chapter 13, to describe Precision Oncology research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Precision Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Precision Oncology by Type
1.3.1 Overview: Global Precision Oncology Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Precision Oncology Consumption Value Market Share by Type in 2022
1.3.3 Diagnostics
1.3.4 Therapeutics
1.4 Global Precision Oncology Market by Application
1.4.1 Overview: Global Precision Oncology Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Hospitals & Diagnostic Laboratories
1.4.4 Healthcare Data Companies
1.5 Global Precision Oncology Market Size & Forecast
1.6 Global Precision Oncology Market Size and Forecast by Region
1.6.1 Global Precision Oncology Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Precision Oncology Market Size by Region, (2018-2029)
1.6.3 North America Precision Oncology Market Size and Prospect (2018-2029)
1.6.4 Europe Precision Oncology Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Precision Oncology Market Size and Prospect (2018-2029)
1.6.6 South America Precision Oncology Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Precision Oncology Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Acrivon Therapeutics
2.1.1 Acrivon Therapeutics Details
2.1.2 Acrivon Therapeutics Major Business
2.1.3 Acrivon Therapeutics Precision Oncology Product and Solutions
2.1.4 Acrivon Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Acrivon Therapeutics Recent Developments and Future Plans
2.2 Bio-Serv
2.2.1 Bio-Serv Details
2.2.2 Bio-Serv Major Business
2.2.3 Bio-Serv Precision Oncology Product and Solutions
2.2.4 Bio-Serv Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bio-Serv Recent Developments and Future Plans
2.3 Exact Sciences Corporation
2.3.1 Exact Sciences Corporation Details
2.3.2 Exact Sciences Corporation Major Business
2.3.3 Exact Sciences Corporation Precision Oncology Product and Solutions
2.3.4 Exact Sciences Corporation Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Exact Sciences Corporation Recent Developments and Future Plans
2.4 Illumina, Inc.
2.4.1 Illumina, Inc. Details
2.4.2 Illumina, Inc. Major Business
2.4.3 Illumina, Inc. Precision Oncology Product and Solutions
2.4.4 Illumina, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Illumina, Inc. Recent Developments and Future Plans
2.5 Invitae Corporation
2.5.1 Invitae Corporation Details
2.5.2 Invitae Corporation Major Business
2.5.3 Invitae Corporation Precision Oncology Product and Solutions
2.5.4 Invitae Corporation Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Invitae Corporation Recent Developments and Future Plans
2.6 Laboratory Corporation of America
2.6.1 Laboratory Corporation of America Details
2.6.2 Laboratory Corporation of America Major Business
2.6.3 Laboratory Corporation of America Precision Oncology Product and Solutions
2.6.4 Laboratory Corporation of America Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Laboratory Corporation of America Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Precision Oncology Product and Solutions
2.7.4 QIAGEN Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Rain Oncology
2.8.1 Rain Oncology Details
2.8.2 Rain Oncology Major Business
2.8.3 Rain Oncology Precision Oncology Product and Solutions
2.8.4 Rain Oncology Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Rain Oncology Recent Developments and Future Plans
2.9 Relay Therapeutics
2.9.1 Relay Therapeutics Details
2.9.2 Relay Therapeutics Major Business
2.9.3 Relay Therapeutics Precision Oncology Product and Solutions
2.9.4 Relay Therapeutics Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Relay Therapeutics Recent Developments and Future Plans
2.10 Strata Oncology, Inc.
2.10.1 Strata Oncology, Inc. Details
2.10.2 Strata Oncology, Inc. Major Business
2.10.3 Strata Oncology, Inc. Precision Oncology Product and Solutions
2.10.4 Strata Oncology, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Strata Oncology, Inc. Recent Developments and Future Plans
2.11 Thermo Fisher Scientific Inc.
2.11.1 Thermo Fisher Scientific Inc. Details
2.11.2 Thermo Fisher Scientific Inc. Major Business
2.11.3 Thermo Fisher Scientific Inc. Precision Oncology Product and Solutions
2.11.4 Thermo Fisher Scientific Inc. Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.12 Variantyx, Inc.
2.12.1 Variantyx, Inc. Details
2.12.2 Variantyx, Inc. Major Business
2.12.3 Variantyx, Inc. Precision Oncology Product and Solutions
2.12.4 Variantyx, Inc. Precision Oncology Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Variantyx, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Precision Oncology Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Precision Oncology by Company Revenue
3.2.2 Top 3 Precision Oncology Players Market Share in 2022
3.2.3 Top 6 Precision Oncology Players Market Share in 2022
3.3 Precision Oncology Market: Overall Company Footprint Analysis
3.3.1 Precision Oncology Market: Region Footprint
3.3.2 Precision Oncology Market: Company Product Type Footprint
3.3.3 Precision Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Precision Oncology Consumption Value and Market Share by Type (2018-2023)
4.2 Global Precision Oncology Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Precision Oncology Consumption Value Market Share by Application (2018-2023)
5.2 Global Precision Oncology Market Forecast by Application (2024-2029)
6 North America
6.1 North America Precision Oncology Consumption Value by Type (2018-2029)
6.2 North America Precision Oncology Consumption Value by Application (2018-2029)
6.3 North America Precision Oncology Market Size by Country
6.3.1 North America Precision Oncology Consumption Value by Country (2018-2029)
6.3.2 United States Precision Oncology Market Size and Forecast (2018-2029)
6.3.3 Canada Precision Oncology Market Size and Forecast (2018-2029)
6.3.4 Mexico Precision Oncology Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Precision Oncology Consumption Value by Type (2018-2029)
7.2 Europe Precision Oncology Consumption Value by Application (2018-2029)
7.3 Europe Precision Oncology Market Size by Country
7.3.1 Europe Precision Oncology Consumption Value by Country (2018-2029)
7.3.2 Germany Precision Oncology Market Size and Forecast (2018-2029)
7.3.3 France Precision Oncology Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Precision Oncology Market Size and Forecast (2018-2029)
7.3.5 Russia Precision Oncology Market Size and Forecast (2018-2029)
7.3.6 Italy Precision Oncology Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Precision Oncology Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Precision Oncology Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Precision Oncology Market Size by Region
8.3.1 Asia-Pacific Precision Oncology Consumption Value by Region (2018-2029)
8.3.2 China Precision Oncology Market Size and Forecast (2018-2029)
8.3.3 Japan Precision Oncology Market Size and Forecast (2018-2029)
8.3.4 South Korea Precision Oncology Market Size and Forecast (2018-2029)
8.3.5 India Precision Oncology Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Precision Oncology Market Size and Forecast (2018-2029)
8.3.7 Australia Precision Oncology Market Size and Forecast (2018-2029)
9 South America
9.1 South America Precision Oncology Consumption Value by Type (2018-2029)
9.2 South America Precision Oncology Consumption Value by Application (2018-2029)
9.3 South America Precision Oncology Market Size by Country
9.3.1 South America Precision Oncology Consumption Value by Country (2018-2029)
9.3.2 Brazil Precision Oncology Market Size and Forecast (2018-2029)
9.3.3 Argentina Precision Oncology Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Precision Oncology Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Precision Oncology Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Precision Oncology Market Size by Country
10.3.1 Middle East & Africa Precision Oncology Consumption Value by Country (2018-2029)
10.3.2 Turkey Precision Oncology Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Precision Oncology Market Size and Forecast (2018-2029)
10.3.4 UAE Precision Oncology Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Precision Oncology Market Drivers
11.2 Precision Oncology Market Restraints
11.3 Precision Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Precision Oncology Industry Chain
12.2 Precision Oncology Upstream Analysis
12.3 Precision Oncology Midstream Analysis
12.4 Precision Oncology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock